The Future of Women’s Health is Here.
Nanosolutions for women’s biggest health problems.
Life-saving screening that fits your life!
Tired of invasive tests and waiting for appointments? CELLECT is pioneering the use of nanotechnology-powered menstrual products to non-invasively collect and preserve DNA for the diagnosis of HPV, cervical cancer, STDs, and other reproductive & gynaecological conditions.
active women develop STDs
Pap tests are outdated—81% of women feel embarrassed during them, and millions delay or avoid them altogether.
The current process for routine screening fits doctor’s schedules, not yours.
Only 10% of women worldwide are tested for sexually transmitted diseases and infections
#ScrapthePap
1 in 4 sexually active women develop STDs.
The current process for routine screening fits doctor’s schedules, not yours.
Pap tests are outdated—81% of women feel embarrassed during them, and millions delay or avoid them altogether.
Only 10% of women worldwide are tested for sexually transmitted diseases and infections.
Don’t get caught with your panties down.
Women Deserve Better!
Detection in 3 Easy Steps
Use
Use a familiar tampon or pad embedded with our nanomaterial
Send
Send your sample for analysis using our pre-labeled packaging
Get Your Results
We’ll reach out to inform you of your accurate results.
Why We Started CELLECT
Collaborators
Our Team
CT Murphy
Founding CEO
Ibukun Elebute
Founding COO
Dr. Marc Aucoin
Advisor (Specialist in Viruses)
Dr. Kim Alexander
Gynaecological Advisor
As Seen in the Media
#ScrapthePap
FAQs
How does CELLECT’s passive alternative to Pap smears address cultural and religious barriers while offering a more comfortable option for cervical cancer screening?
CELLECT provides a passive alternative to Pap smears by using menstrual blood collection through menstrual products, eliminating the need for invasive procedures like swabs or speculums. This makes our solution especially valuable for women who may face cultural or religious barriers that discourage or prevent them from undergoing traditional cervical cancer screenings. Unlike swabs, CELLECT’s technology doesn’t require anything to be inserted, offering a more comfortable and discreet option that can be done in the privacy of one’s own home.
What solution does CELLECT offer for women who do not menstruate?
For women who do not menstruate, CELLECT is actively exploring the use of other vaginal fluids, such as discharges, as an alternative sample. Our proprietary technology is designed to work with very small fluid volumes— as little as 15 mm³ — allowing us to achieve the same diagnostic goals. This ensures that our solution remains inclusive and adaptable, providing a non-invasive, accurate method for women across different health stages.
Can CELLECT be used to differentiate between low-risk and high-risk HPV strains?
CELLECT collects DNA from menstrual blood using its proprietary nanomaterial, which isolates and retains cervical and endothelial cells. This DNA can then be analyzed using established diagnostic tests, such as HPV hybridization assays. The lab processing techniques CELLECT uses are the same as those applied in standard HPV tests, allowing for the differentiation between high-risk and low-risk strains.